Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0009-8981(80)90176-x | DOI Listing |
Clin Nucl Med
September 2024
From the Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX.
A 60-year-old man with T2aN0M0 prostate cancer underwent intensity-modulated radiotherapy targeting the prostate and seminal vesicles. Experiencing biochemical recurrence after 6 years, 68 Ga-PSMA-11 PET/CT revealed focal radioactivity in the posterior midline of the prostate, identified as a prostatic utricle cyst on subsequent MRI. Similar findings appeared in a previous 18 F-piflufolastat PET/CT, with negative biopsy results.
View Article and Find Full Text PDFIndian J Nucl Med
March 2024
Department of Nuclear Medicine, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India.
Rev Sci Instrum
April 2024
Institute for Quantum Computing and Department of Physics and Astronomy, University of Waterloo, Waterloo, Ontario N2L 3G1, Canada.
Trapped ions for quantum information processing have been an area of intense study due to the extraordinarily high fidelity operations that have been reported experimentally. Specifically, barium trapped ions have been shown to have exceptional state-preparation and measurement fidelities. The 133Ba+ (I = 1/2) isotope in particular is a promising candidate for large-scale quantum computing experiments.
View Article and Find Full Text PDFCancers (Basel)
March 2024
Service of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland.
Background: F-FDG PET/CT is performed for the assessment of radioactive iodine non-avid disease in patients with DTC. In patients prepared by THW, increased pituitary uptake of F-FDG in the absence of pituitary disease may reflect the physiological activation of pituitary thyrotroph cells by hypothyroidism. This study aimed to compare pituitary F-FDG uptake in patients with DTC under THW vs.
View Article and Find Full Text PDFPharmaceuticals (Basel)
February 2024
Department of Nuclear Medicine, Copenhagen University Hospital, Herlev and Gentofte, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark.
Alzheimer's disease (AD) is a neurodegenerative disorder with increasing global prevalence and accounts for over half of all dementia cases. Early diagnosis is paramount for not only the management of the disease, but also for the development of new AD treatments. The current golden standard for diagnosis is performed by positron emission tomography (PET) scans with the tracer [C]Pittsburg Compound B ([C]PiB), which targets amyloid beta protein (A) that builds up as plaques in the brain of AD patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!